Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Vascular Surgery Complications Increased by Hyperglycemia

By HospiMedica International staff writers
Posted on 21 Jun 2017
Hyperglycemia can increase complications and mortality in patients undergoing vascular procedures, including those who are not diabetic, according to a new study.

Researchers at the University of Missouri (MU; Columbia, USA) conducted a study in 3,586 patients with peripheral artery disease (PAD) admitted for elective lower extremity surgical procedures performed between September 2008 and March 2014, in order to evaluate the relationship of postoperative hyperglycemia--defined as blood glucose over 180 mg/dL--with sociodemographic characteristics, acute and chronic diagnoses, infections, hospital length of stay, and 30-day readmission.

The results of the study indicated that 22% of patients undergoing vascular procedures had suboptimal glucose control (hyperglycemia), which was associated with poorer outcomes in patients both with and without diabetes, including increased infection rates (23% vs 14%) and more acute complications such as fluid and electrolyte disorders, acute renal failure, postoperative respiratory complications; increased hospital stays (6.9 vs 5.1 days); and an 8.4-times odds of dying in the hospital. More...
The study was published on April 17, 2017, in the Journal of Vascular Surgery.

“I think of most interest was that diabetes alone was not associated with an increase in infection rates, length of stay or mortality,” said lead author Todd Vogel, MD, chief of the division of vascular surgery at MU School of Medicine. “Although more research is needed, this suggests that post–procedure hyperglycemia is a significant risk factor for outcomes following lower extremity vascular procedures. Glucose management may represent an important method for improving outcomes following surgical interventions.”

PAD is a narrowing of the peripheral arteries due to atherosclerosis, and is most common in the arteries of the pelvis and legs. The most common symptoms of PAD are cramping, pain, or tiredness in the leg or hip muscles while walking or climbing stairs, which is temporarily relieved by rest. PAD sufferers have four to five times more risk of heart attack or stroke, and if left untreated, it can lead to gangrene and amputation.

Related Links:
University of Missouri


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.